---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-248691"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:16:49.825596+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Elevance Health closes $5.2B multi-tranche notes offering; proceeds for general corporate purposes

## Summary
- Issued $5.2B aggregate principal across six series: 2026 (4.500%), 2030 (4.750%), 2031 (4.950%), 2035 (5.200%), 2055 (5.700%), 2064 (5.850%).
- Net proceeds of approximately $5.138B after underwriting discounts and expenses.
- Proceeds intended for working capital, acquisitions, debt repayment, and share repurchases.
- Notes issued under existing indenture; underwriters include Citigroup, Morgan Stanley, Wells Fargo.

## SEC filing metadata
- accession: 0001193125-24-248691
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312524248691/0001193125-24-248691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312524248691/d888716d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-248691
- JSON: https://secwatch.observer/filing/0001193125-24-248691.json
- Plain text: https://secwatch.observer/filing/0001193125-24-248691.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.